Cancer is a war waged on a submicroscopic molecular scale. Taking a keen interest in this war wouldn’t be a bad idea, as its outcome will eventually determine whether about a third of us will live or die. The advent of Nagalase testing and GcMAF therapy gives us reason to hope and expect that we can soon eradicate the specter of cancer. There’ll be problems along the way.
Cancer is many things to many people. From the point of view of the cancer patient, cancer may be seen as a fear-inducing, life-threatening nightmare. From the perspective of a family member, who may be called upon to provide emotional, physical, and/or financial support, how could cancer be anything other than stressful? From the viewpoint of the doctor, who must find and treat the cancer to the best of his or her ability, cancer is both a backbreaking, sometimes thankless, job and an opportunity to provide exceptional, loving patient care.
The molecular biologist, however, views cancer as a vicious and protracted battle waged between cancer cells and immune cells. This cancer war—a strategic dance of cellular activities—is breathtaking in its elegance and sophistication.
Two cell types—cancer cells and macrophages—comprise the main forces of the opposing armies. Both have massive numbers of personnel and awesome weaponry at their disposal, and both have a strategy for winning.
Remember, this is WAR!!! Cancer cells want to survive and grow so they can kill you. That is their job description, and they are extremely good at what they do. On the other side our immune system consists of enormous numbers of crafty white blood cells doing their best to defend us.
Taking a keen interest in this war wouldn’t be a bad idea, as its outcome will eventually determine whether about a third of us will live or die. Hundreds of billions of cellular warriors on both sides will die before it’s all over. The stakes don’t get much higher. If the cancer (or virus) wins, you will cease to exist.
GcMAF treatment and Nagalase testing will dramatically change the way this war is fought. With some hard work and perhaps a few lucky breaks, we now have reason to hope—and even expect—that we can eradicate cancer. Not just in our lifetimes, but in the next few years.
When I said “a few lucky breaks” above, I was referring to our medical care delivery system, including the federal government, Big Pharma, insurance companies, cancer care facilities and cancer specialists. For a multiplicity of reasons—including but not limited to the flow of cash—this gargantuan beast resists change. GcMAF and Nagalase are the two new elephants in the room. Accepting that these benevolent behemoths have moved in for good—and making space for them within our current cancer care system—is going to be the challenge of the century.
People will continue to die because of the reluctance of modern medicine to embrace change. If we started screening everyone for elevated Nagalase today, and giving GcMAF to those with high levels, we could eradicate cancer literally overnight. Left behind in the rubble would be some some very unhappy drug salesmen and more than one bored but retrainable oncologist with an overdue Mercedes payment.